Cure My Disease

Don't miss your cure!

 Log in / Sign up

New app aims to help hispanic kids breathe easier

NCT ID NCT05892302

Disease control Sponsor: University of Texas at Austin Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an app called Asma Guardián, designed to help Hispanic children with asthma. The app encourages families to see an asthma specialist, use controller medication, and improve the home environment. 37 children aged 5-12 took part, and the study compared app users to those receiving usual care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

37 people

The number who actually took part.

Started

Mar 2024

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

5 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Provision of signed and dated informed consent forms. 2. Who has a child who is 5-12 years of age 3. Whose child meets criteria for current persistent asthma defined as either: 1. On a long-term controller medication for asthma, or 2. Meet NAEPP guideline requirements for persistent disease:)(35) * Asthma symptoms 3 or more days per week over the past 2 weeks OR * Nocturnal asthma symptoms at least 3 times in the past month 4. Whose child has had an asthma exacerbation, defined as an oral steroid burst, in the previous 12 months 5. Parent/Caregiver identifies as Mexican American or other Hispanic descent 6. Whose child has clinician diagnosed asthma 7. Access to necessary resources for participating in a technology-based intervention (i.e., computer, smart phone, internet access) 8. Whose child is not currently participating in another asthma study. The parent/caregiver is the primary study participant, but the child will be asked to complete some surveys at baseline and six months, so an assent will be obtained from the child. Exclusion Criteria: * An individual who meets any of the following criteria will be excluded from participation in this study: 1. Unwilling to provide consent for research activities 2. Cognitive inability to provide consent 3. Whose child has evidence of other chronic lung or significant cardiovascular disease 4. Whose child has a history of intubation for asthma

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Asthma in children are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

childhood onset asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Asthma in children

Contacts and locations

Locations

  • University of Texas at Austin

    Austin, Texas, 78712, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.